🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective was to evaluate the persistence of bactericidal antib...
Status
Completed
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Start Date
2010-07
Trial ID
NCT01148017
Treatments Being Tested
The purpose of this study is: To assess whether there are differences in a...
Status
Completed
Location
Health Protection Agency
Start Date
2008-02
Trial ID
NCT00625677
Treatments Being Tested
This is a study to evaluate the immunogenicity, safety, and reactogenicity ...
Status
Completed
Location
Benchmark Research (California)
Start Date
2021-05-28
Trial ID
NCT04927065
The aim of the study is to assess the safety, and immunogenicity of AZD2816...
Status
Completed
Location
Research Site
Start Date
2021-06-27
Trial ID
NCT04973449
To assess persistence of antibody titers 17-18 months after primary immuniz...
Status
Completed
Location
Dipartimento di Medicina e Scienze dell'Invecchiamento, Università G. D'Annunzio, Via dei Vestini
Start Date
2007-10
Trial ID
NCT00561184
Treatments Being Tested
This is a phase IV, open-label, non-randomized study to demonstrate superio...
Status
Recruiting
Location
Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
Start Date
2025-05-13
Trial ID
NCT06803524
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of 13-...
Status
Completed
Location
Huaiyin District Center for Disease Prevention and Control
Start Date
2018-06-23
Trial ID
NCT03574389
The study will evaluate the efficacy of Ad26.COV2.S in the prevention of mo...
Status
Completed
Location
Achieve Clinical Research, LLC
Start Date
2020-11-12
Trial ID
NCT04614948
Treatments Being Tested
A Phase III randomized controlled multi-centre trial to evaluate the effica...
Status
Active Not Recruiting
Location
CCVTM, University of Oxford, Churchill Hospital
Start Date
2021-04-29
Trial ID
NCT04704830
Treatments Being Tested
The aim of this study is to assess the immunogenicity and safety of AZD1222...
Status
Terminated
Location
Research Site
Start Date
2022-01-31
Trial ID
NCT05057897
Treatments Being Tested